Pharm - #8 Flashcards

1
Q

most, but not all, drugs produce their effects by interacting with what?

Biological response to drugs are graded. EXPLAIN

A

Receptors

  1. increasing dose increases the response (up to some maximal point).

– biologic effects of drugs can be therapeutic or toxic,
depends on: the drug, the dose and its receptor “selectivity”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Drug Nomenclature: Drugs are referred to by a name that reflects what?

A

their most prominent site of action or clinical effect

– Most drugs will likely interact with many other receptors within a given clinical dose range used therapeutically. (not just at target site, but other sites as well)

**Drug interactions with one or more receptor subtypes are determined by the drug’s chemical and structural properties, not by the name given to it by humans.

(ex: beta blocker also has high affinity for seratonin receptors)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the following:

  1. Electrostatic (+ and -)
  2. Hydrogen Bonding (dipolar interactions)
  3. Van de Waal’s Forces (at closer distances)  overlapping electron clouds
  4. Hydrophobic Forces (between lipophilic components)
A

The Chemical Forces that Contribute to Drug Binding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

MOST DRUG BINDING INTERACTIONS ARE ____.

Most Drug Binding Interactions DO NOT Form a____Bond.

IMPORTANT:all drugs interact only with unoccupied free receptors

A
  1. REVERSIBLE
  2. Covalent
  3. Drug “displacement” generally does NOT occur in drug receptor interactions
    - Reversible interaction between drug & receptor should be viewed as a dynamic equilibrium process. Thus the drug is either on or off the receptor at any point in time.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

______ - can bind a substance (e.g. drug) but are not themselves capable of initiating a subsequent response, whereas

______ – can bind a substance and are capable of initiating a subsequent response.

A

Binding Sites

Receptors

-Receptors represent only the first step in the transfer of drug information to the system ( D + R Response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What happens after receptor amplification?

A

Signal Amplification

  • single drug interaction leads to amplification

Gives rise to concepts of efficacy, potency, and spare receptors (reserve capacity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

II. What is the Relationship between Drug Concentration and Receptor Occupation ?

For any receptor population, the percent occupied (“fractional occupancy”) is dependent only on the drug’s what? (2)

A

To initiate a response, drugs need to occupy receptors

  1. Affinity and
  2. Concentration (or dose)
    - Drug Binding to Receptors is a Dynamic Equilibrium Process
    - the term k2/k1 (or koff/kon ) is the equilibrium dissociation constant (aka, the drug affinity constant) which is denoted by the term KD .
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What does the KD value represent?

  1. *Drug Affinity and KD values are ______ related

What ELSE does the Kd constant represent?

A
  1. The KD value (i.e. affinity constant) of a drug represents a measure of the propensity of a drug to bind to a given receptor (a.k.a.,… its affinity
  2. Inversely
  3. The Affinity Constant (i.e., the KD) of a drug also represents the concentration of that drug required to occupy 50% of a receptor population.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

The Binding of Drugs to Receptors is Dictated by the what equation?

A

Simple Fractional Occupancy Equation

Fractional Occ = 1/ [ 1+ Kd/[D]}

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

receptor fractional occupancy is dependent only on what 2 things?

A
  1. Drug affinity

2. Drug concentration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

total number of receptors occupied by a drug will depend on what 2 factors?

What type of plot will result from the plotting of concentration vs. receptor occupation (where drug conc. is in units Kd)

A
  1. The fraction of the receptor population occupied
  2. the number of receptors in a given tissue (Bmax)
  3. LINEAR PLOT
    - For example: If the KD of a drug is 1nM, then a conc. of 1nM would be a conc. of 1 KD unit, 2nM would be 2 KD units, etc. If another drug’s KD were 1uM, then it would take a conc. of 1uM to be at a 1KD conc for that drug, 2uM to be at 2 KD units of conc., etc.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

At its KD concentration, a drug will occupy ____of its receptor population

What happens once we approach Kd? Once we exceed?

A
  1. 50%

-First we see a linear increase, then at the drug’s Kd a drug will occupy 50% of
receptor

-as we approach Kd and exceed we tail off and get a SMALL increase

**Increasing dose will increase receptor occupation in a NON-LINEAR fashion over most of the dose range.

-As the concentration of drug increases, the fraction of receptors occupied by the drug will increase from 1-91% over approximately 3 orders of magnitude (3 log units of drug conc.) about its Kd value, as shown in the figure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

The magnitude of a drug response will be some function of what?

A

Total number of receptors occupied
( fractional occupancy * receptor density)

-RESPONSE = ƒ [(Fractional Occupancy) (Receptor Density)]

= ƒ [ Total # Receptors Occupied]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Drug Selectivity – will be dependent on the relative _____ of a drug
for various receptors.

  1. selectivity will ____ as drug dose is increased
A

affinities

-(i.e. comparative KD values for various receptors).

  1. decrease
    - - as conc. increases, likely to interact with sites that interact with SIDE EFFECTS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

DRUG SELECTIVITY:

Remember- all drugs can interact with any receptor at_____

&

it takes at least____ log units of concentration to occupy 1-91% of receptors

The “selectivity window” of a drug is dependent on the what?

A
  1. high enough doses
  2. 3 log units to occupy 1-91% of receptors
  3. drug dose or concentration range employed.
    - It can be difficult to obtain this range in vivo where numerous factors are operative (drug distribution, metabolism, tissue receptor heterogeneity)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

_____;this is the correspondence between the amount of drug and the magnitude of the effect;

A

Dose Response Relationship

-increasing the dose, increases the effect in a graded manner.

17
Q

What is the simple occupancy theory?

A

1:1 relationship between occupation & response

-It’s simple……..
but doesn’t represent the dose-response relationship in most biologic systems

  1. The magnitude of the pharmacological effect is linearly proportional to the NUMBER of receptors occupied by the drug
  2. the maximum response Is obtained when all receptors are occupied
18
Q

What did the modified occupancy theory give rise to? What was it an expansion of?

A

gave rise to:

  1. Potency
  2. maximal efficacy

An expansion of the original theory to account for experimental findigns

The response of a drug was some positive function of receptor occupancy (i.e. not necessarily linearly proportional to the percent of receptors occupied

Maximum effects could be produced by an agonist occupying only a small proportion of receptors

Different drugs may have varying capacities to initiate a response

19
Q

Potency refers to what?

What does it depend on (2)?

A
  • refers to the concentration or dose of drug needed to produce 50% of that drugs maximal response (EC50 or ED50 value)
  1. Affinity for the receptor
  2. Efficiency with which the receptor activation is coupled to response
20
Q

______: the maximal response produced by the drug.Used synonymously with?

What is the intrinsic activity of the following:

  1. Full agonists
  2. Partial Agonists
  3. Antagonists(neutral)
  4. Inverse agonists (negative antagonists)

Why are antagonists considered “neutral”?

A

Maximal efficacy

Intrinsic Activity
-This can be determined directly from the graded dose –response curve and is the limit of the dose response curve on the response axis

  1. Full agonists I = 0
  2. Partial Agonists IA
21
Q

A negative antagonist (or inverse agonist) can do what?

A

Reduce the constitutive activity of receptors

22
Q

Remember: Biological Activity CANNOT Be Determined From what?

A

Fractional Occupancy

example of 3 graphs:
Shown below, 3 drugs have equal affinity for a receptor, yielding equivalent fractional occupancy with dose, despite having different biological activities
= different response

could be antagonist, full agonist,
partial agonist

23
Q

Dose response curves demonstrate the concepts of _____ and ____

Describe the example of Morphine & Petazocine

A

Efficacy & Potency

-Efficacy and Potency are Independent Properties of a Drug

  1. different POTENCY
  2. same degree of pain relief efficacy (but different MAXIMUM efficacy)

ex:Morphine is more potent so need a lower dose
but both achieve the same pain relief efficacy

Increase dose = increase degree of pain relief up to some max response

Pentazocine also has some response, but will never achieve the same degree of pain relief
as with Meparidine  both drugs equipotent, but DIFFERENT MAXIMAL EFFICACY

24
Q

True or false:The Clinical Effectiveness of a Drug Depends on it’s Maximal Efficacy (Emax) not Potency (ED50)

A

TRUE!

reference the example fo the graph
- max efficacy is the limit of the graph

  • ED50 is the same for morphine & petnamazocine for example
25
Q

Define:

Systems in which maximal response is achieved by doses of agonists that occupy only a SMALL percentage (or fraction ) of receptors

True or False: This means only some receptors are functional, and others are not

A

FALSE: This doesn’t mean that only some receptors are functional and others are not (i.e. “spare”).

All receptors are considered to be EQUALLY functional, but its NOT required that ALL receptors be occupied to achieve a maximal response

  • generally because amplification is so robust
26
Q

What can help identify evidence of SPARE receptors?

A

identified from the “steepness” or dose-range required to achieve Emax in a D-R curve

NOTE that a larger dose range is required for noradrenaline to elicit a maximal response in Tissue 1 compared to Tissue 2

THEREFORE: tissue 2 has MORE spare receptors

LARGER RESERVE = smaller occupancy

27
Q

What does the following help us identify:it takes 3 log units of concentration for a drug to occupy 91% of any receptor population yet a maximal response occurs over a more narrow dose range (

A

Spare Receptors

28
Q

EXPERIMENTAL DETERMINATION OF SPARE RECEPTORS:

How does one achieve Sequential increase in ED50 and EC50 with no change in Emax ?

How can Emax be changed in Experimental Determination of spare receptors? (example)

A

Reduce the DENSITY (aka Fractional Occupancy)

As you reduce receptor density = shift to right, increase in ED50

  1. Reduce the number of Spare Receptors
    ex: if # receptors needed for Emax = 20, and you decrease to
29
Q

What is “surmountable” antagonist?

What are the 3 effects they produce to the graph of agonist dose vs. percent of maximum?

Does E max change?

Can they be overcome?

A

COMPETITIVE ANTAGONISM (“SURMOUNTABLE”)

1) Shift to the right in DR Curve,
2) Increase in ED50, 3) No change in Emax

-Increase antagonism
by increasing DOSE or
concentration of AGONIST will
maintain E max originally had for that agonist

HIGHER CONCENTRATION required to compete with antagonist in order to occupy the same number of receptors to produce a response equal to that observed in the absence of antagonist.

30
Q

What is an “insurmountable” antagonist?

How do they affect the following:

  1. Emax
  2. ED50

Can they be overcome?

A

Non – competitive = insurmountable = NO SPARE RECEPTORS (reduced density)

Non – competitive antagonists bind to the receptor and result in a change in the receptor that effectively removes it from the sites available to interact with the drug. (reversible or irreversible).

  1. DECREASE Emax
  2. No change in ED50
    - The remaining receptors would exhibit the same affinity (Kd) for the drug and thus the ED50 would not be altered.

If there is no receptor reserve, there would be a decrease in the maximal response (Emax) due to the loss of available receptors to be activated.

31
Q

WHat is the effect of administering a Partial Agonist?

Why?

A

ANTAGONISM
- will diminish activation of full agonist
-will give LESS of a response
(1 + 0/5 is actually 0.5 not 1.5)

Since partial agonists can bind to the full complement of a receptor population but CANNOT produce the maximal response of full agonists, THEY CAN REDUCE THE MAXIMAL RESPONSE OF FULL AGONISTS WHEN BOTH DRUGS ADMINISTERED TOGETHER

(cannot produce the maximal response of full agonists)

32
Q

Non Pharmacological Means to Antagonize Drug Effects

State the following:

  1. the use of opposing pathways to antagonize the effects of a drug
  2. via chemical inactivation of a drug (example)
    • one drug may affect the metabolism or pharmacokinetics of another drug
A
  1. Physiologic Antagonism
  2. Chemical Antagonism
    Ex: protamine (+ charge) inactivates heparin (-)
    Less specific, and less easy to control that the effects of a receptor specific antagonist

3.Biologic Antagonism

33
Q

What is the QUANTAL Dose response curve?

Where is it obtained?

A
  • the relationship between drug dose and a specified effect in a population of individuals
    2. This is obtained from the cumulative frequency distribution of doses of drug that produce a specified (i.e. quantal) effect in a patient or animal population.
34
Q

What are 3 things the Quantal Dose Response Curve can be used to obtain?

A
  1. Can be used to obtain median effective dose ED50.
    Dose at which 50% of people will exhibit a specified effect
  2. Used to obtain INDEX of SELECTIVITY of a drugs actions by comparing its ED50 for different specified effects
  3. Used to determine THERAPEUTIC INDEX representing some estimate of safety of a drug. It is the ratio of TD50 or LD 50 to the ED50 determined from quantal dose response curves
35
Q

How is the Quantal Dose Curve obtained?

1st?

2nd?

3rd?

4th & final?

A
  1. First: specify your endpoint effect (or multiple endpoints) that can be answered in digital fashion; Yes or No ! (sedation, decongestation, anxiety)
  2. Give a low dose of drug and determine the number of individuals that exhibit the effect (they do or they don’t – there’s no grading on a curve here, its PASS or FAIL)
  3. Give a higher dose of drug and again determine the number of individuals (percent of population) that exhibit the effect
  4. Continue this strategy of increasing the dose until you obtain the effect in all individuals in the population – then ADD it all up and plot !
36
Q

ED50 is always less than what in the quantal dose resposne curve?

A

LD50!

As you increase dose, what percentage of pop. responds with specified endpoint to given dose

37
Q

What 3 things are determined by Quantal Dose Response Curve?

A
  1. median effective Dose (ED50)
  2. Index of SELECTIVITY of a drugs action
    - by comparing its ED50 for different specified effects
  3. An ESTIMATE of the degree of SAFETY for a Drug for a Specified Effect
    (i. e. the Therapeutic Index TD50/ED50 or LD50 /ED50
38
Q

What is a more clinically relevant index of safety other than quantal dose curve?

Ex?

A

Therapeutic Window – a more clinically relevant index of safety

**This is the Dosage Range between the minimum effective therapeutic dose and the minimum toxic dose (e.g. 8mg/L – 18mg/L theophylline)
EX: theophylline has a narrow therapeutic window!!!

*Want ED50 and LD50 to be as FAR as possible from one another = less toxicity and safer

39
Q

Drugs can have the same therapeutic INDEX, but a small therapeutic window. True or false?

Which is better to assess drug safety?(therapeutic index or therapeutic window)

A

TRUE

  • do not prescribe these drugs

Take Home: Drug safety can be better assessed from the Therapeutic Window than from the Therapeutic Index